✦ LIBER ✦

Troxatyl is effective in non-lymphoid blastic phase chronic myeloid leukemia (CML-BP)

✍ Scribed by F. Giles; M. Talpaz; C. Bivins; J. Jolivet; H. Kantarjian

Book ID: 117657980
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 186 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80610-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HCVAD plus imatinib or dasatinib in lymp

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia

✍ Strati, Paolo; Kantarjian, Hagop; Thomas, Deborah; O'Brien, Susan; Konoplev, Ser 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

PCN124 COST-UTILITY ANALYSIS OF DASATINI

PCN124 COST-UTILITY ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) ON CHRONIC (CP), ACCELERATED (AP) AND BLAST (BP) PHASES IN BRAZIL

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Erythropoietin is effective in improving

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

✍ Jorge Cortes; Susan O'Brien; Alfonso Quintas; Francis Giles; Jianquin Shan; Mary 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND Myelosuppression occurs in up to 50% of patients with chronic myeloid leukemia (CML) who are treated with imatinib and ≥ Grade 3 myelosuppression is reported in approximately 10% of patients. ## METHODS The authors investigated the prognostic significance of anemia occu

Cytogenetic analysis is non-informative

Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-α (IFN-α) therapy

✍ M.Christina Cox-Froncillo; Maria Cantonetti; Mario Masi; Raffaele Lentini; Paolo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Imatinib mesylate induces hypophosphatem

Imatinib mesylate induces hypophosphatemia in patients with chronic myeloid leukemia in late chronic phase, and this effect is associated with response

✍ S. Osorio; A. García Noblejas; A. Durán; J.L. Steegmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

Synergistic interactions between 12-0-te

Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib

✍ Baijun Fang; Yongping Song; Zhengtao Han; Xudong Wei; Quande Lin; Xiaoxiu Zhu; R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 107 KB